An influential Republican congressman on Monday cautioned against amending federal spending legislation to rebuke six drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.
During a July 26 U.S. House Rules Committee hearing, Rep. Michael Burgess (R-Texas)
…
AstraZeneca and the federal government have filed a new round of briefs in the drug manufacturer’s 340B contract pharmacy lawsuit, this round focused on the government’s May 17 letter telling the company its contract pharmacy actions are illegal.
In a
…
The 340B program “will not be overlooked” if the drug industry strikes a grand bargain with Congress and the Biden administration on lowering drug prices, biopharma policy analyst Michael McCaughan predicted this week during a talk on drug pricing reform
…
Drug manufacturer Novo Nordisk is giving 340B covered entities refunds for overcharges on two package sizes of its Tresiba FlexTouch insulin pen and on 10 milliliter vials of its Fiasp brand insulin.
The U.S. Health Resources and Services Administration (HRSA)
…
Retired U.S. Sen. Mike Enzi (R-Wy.), who co-led inquiries into stewardship of the 340B program while in Congress, died on Monday after being injured in a bicycle accident in his hometown of Gillette, Wyo. He was 77.
Enzi was a
…
The U.S. House voted this evening “to highlight the need to protect the integrity of the 340B program by halting pharmaceutical manufacturers’ unlawful actions that have resulted in overcharges to 340B covered entities.”
Reps. Abigail Spanberger (D-Va.) and David McKinley
…
UPDATE Tuesday, July 27, 2021, 1:45 p.m. Eastern—Drug manufacturer Novartis provided the following statement:
“Novartis recently notified the Health Resources and Services Administration (HRSA) that we inadvertently neglected to offer the 340B ceiling price to covered entity types added by
…
Groups whose members include 340B hospitals have thrown their support behind mandatory COVID-19 vaccination policies for hospital and health system personnel.
The Association of American Medical Colleges (AAMC) on July 16 urged its member institutions to require vaccinations for
…
It could take federal courts years to ultimately resolve drug manufacturers’ lawsuits over whether they must charge lower prices when 340B covered entities use contract pharmacies, a hospital association leader said yesterday during her remarks opening the 340B Coalition’s virtual
…
Rear Adm. Krista Pedley, Director of the U.S. Health Resources and Services Administration’s (HRSA) Office of Pharmacy Affairs (OPA), gave a brief update on the 340B program during yesterday’s 340B Coalition virtual summer conference. She explained that “due to current
…*Sign up for news summaries and alerts from 340B Report